| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.7 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |